10x Science
PrivateLast Round
Seed
Apr 22, 2026
Est. Valuation
$3.66B
Total Funding Raised
$223.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
10x Science is a biotechnology company that provides an AI-native platform for next-generation protein characterization to accelerate drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Compliance, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
10x Science Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
10x Science Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 22, 2026 | ||||
| Accelerator | Jan 1, 2026 | ||||
| IPO Announced | Sep 12, 2019 | ||||
| Series D Extension | Jan 7, 2019 | ||||
| Series D | Apr 26, 2018 | ||||
Series C | Mar 17, 2016 |
Key People
Founding team and executive leadership
10x Science Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wells Fargo Strategic Capital | Series D |
| Founder Factor | Seed |
| Fidelity Management & Research Company | Series D Extension, Series D, Series C |
| BofA Securities | IPO |
| SoftBank Group | Series C, Series D Extension, Series D |
| Paladin Capital Group | Series C, Series B, Series D Extension, Series D |
| Foresite Capital | Series C, Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Open roles increased to 2, 6x the trailing average.
- Jun 15, 2026
Open roles increased from 0 to 1, representing 33% of headcount.
10x Science Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 10x Science's valuation, stock price, and market status.